How much is AbCellera Biologics worth in 2026?

AbCellera Biologics has a current valuation of N/A based on their Later Stage VC (Series B) round and secondary market data.

How much funding has AbCellera Biologics raised?

AbCellera Biologics has raised N/A in total funding across 1 funding rounds.

AbCellera Biologics

Drug Discovery

AbCellera Biologics valuation and funding history | Last updated: May 27, 2020 | 1 funding rounds

Current Valuation

N/A

As of May 27, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series B)

$105.0M

Last Funding

May 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 27, 2020	Later Stage VC (Series B)	$105.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

AbCellera Biologics is currently valued at N/A as of May 27, 2020.

Track AbCellera Biologics Valuation Updates

Get notified when AbCellera Biologics raises new funding or valuation changes

Explore More Data

Detailed analysis for AbCellera Biologics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock AbCellera Biologics's valuation history, funding rounds, and growth metrics.

No credit card required

What is AbCellera Biologics Worth in 2026?

AbCellera Biologics is a leading private company in the Drug Discovery sector. Track AbCellera Biologics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How AbCellera Biologics Valuation is Determined

Private company valuations like AbCellera Biologics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.